Our Opinion

CervoMed Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company mentioned on its website that it exploits animals for product testing.

“In animal models, CervoMed and others have shown that if you treat synaptic dysfunction at the early stages of disease, you’re able to restore synaptic function and avert neuron death, giving us new hope and optimism for treating dementia with Lewy bodies and other neurological disorders.” Read the following article

Company Description

CervoMed Inc., a biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. Its lead drug candidate is neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer’s diseases, frontotemporal dementia, and ischemic stroke recovery. The company also develops EIP200 for central nervous system which is in preclinical trials. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.

Company Website: https://www.cervomed.com